1. Home
  2. PARR vs TMDX Comparison

PARR vs TMDX Comparison

Compare PARR & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Par Pacific Holdings Inc.

PARR

Par Pacific Holdings Inc.

HOLD

Current Price

$79.73

Market Cap

2.9B

Sector

Energy

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$76.15

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARR
TMDX
Founded
1984
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
PARR
TMDX
Price
$79.73
$76.15
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$70.17
$148.22
AVG Volume (30 Days)
929.1K
829.8K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
1313.56
382.18
EPS
1.10
0.20
Revenue
$2,443,066,000.00
$605,494,000.00
Revenue This Year
N/A
$24.25
Revenue Next Year
$3.78
$18.75
P/E Ratio
$72.38
$371.40
Revenue Growth
30.99
37.13
52 Week Low
$26.83
$60.11
52 Week High
$82.29
$156.00

Technical Indicators

Market Signals
Indicator
PARR
TMDX
Relative Strength Index (RSI) 74.07 55.39
Support Level $55.45 $64.87
Resistance Level N/A $79.60
Average True Range (ATR) 3.28 3.26
MACD 0.59 0.29
Stochastic Oscillator 87.63 70.63

Price Performance

Historical Comparison
PARR
TMDX

About PARR Par Pacific Holdings Inc.

Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments: Refining. Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operating licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: